Data as of Q4 2025 (Dec 31, 2025)
โณ
Showing Q4 2024 data
AlphaMark Advisors, LLC's Q4 2025 filing not yet available. Expected by Feb 14, 2026.

AlphaMark Advisors, LLC

โ€ขCIK: 1348183โ€ขFiling: Q4 2024

**AlphaMark Advisors, LLC** manages $231M across a diversified portfolio of 612 positions. The fund exhibits significant allocations to major indices and sectors, notably holding $14.3M in IVV and $10.4M in XLK. Further concentration is visible in XLV ($10.3M) and SPY ($9.3M), indicating a strategic focus across technology, consumer discretionary, and broad market exposure. This positioning suggests a systematic approach targeting established market leaders and sector rotation opportunities.

Total AUM
$231.0M
QoQ Performance
-20.3%
Positions
602
Top 10 Concentration
40.0%
Latest Filing
Q4 2024

Top Holdings Allocation

IVV
IVV6.2%
XLK4.5%
XLV4.5%
SPDR4.0%
PG3.7%
DBEF3.5%
FNDE3.5%
XLF3.3%

๐Ÿ“ˆ Biggest Buys

XLV
Health Care SPDR
+11.0%
4.5% of portfolio
MBSF
Regan Floating Rate MB
+22.6%
1.8% of portfolio
IWM
iShares Russell 2000
+584.8%
0.4% of portfolio
XLK
Technology SPDR
+6.1%
4.5% of portfolio
DBEF
Deutsche X-tackers MSC
+7.8%
3.5% of portfolio

๐Ÿ“‰ Biggest Sells

IVV
iShares S&P 500
-4.3%
6.2% of portfolio
IBM
Intl Business Machines
-29.6%
0.5% of portfolio
โ€”
SPDR Trust Unit SR
-2.6%
4.0% of portfolio
PG
Procter & Gamble Co
-2.1%
3.7% of portfolio
GS
Goldman Sachs Group In
-5.9%
1.0% of portfolio

Sector Breakdown

Other78.5%
ETF6.4%
Technology4.8%
Consumer2.7%
Financial2.4%
Healthcare2.2%
Industrial1.0%
Consumer Staples0.9%

๐Ÿšช Exited Positionssold since Q3 2024

โ€”
AlphaMark Actively Man
SOLD
$29.4M
LUMN
Lumen Technologies Inc
SOLD
$547.0K
โ€”
Signet Group New Adr
SOLD
$452.0K
HTD
Corcept Therapeutics
SOLD
$451.0K
UAO
Sterling Infrastructur
SOLD
$437.0K
+474 more exited positions

Changes from Q3 2024

NEW7 new positions
โ†‘108 increased
โ†“45 decreased

Historical Filings

Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023